TickerFacts.

BIOCRYST PHARMACEUTICALS INC (BCRX) — Operating Income

Annual figures by period end, from SEC filings.

2009-12-31: -$13.74M2010-12-31: -$34.36M2011-12-31: -$49.59M2012-12-31: -$33.89M2013-12-31: -$30.72M2014-12-31: -$45.77M2015-12-31: -$39.44M2016-12-31: -$48.61M2017-12-31: -$57.41M2018-12-31: -$94.22M2019-12-31: -$99.45M2020-12-31: -$174.76M2021-12-31: -$177.72M2022-12-31: -$148.44M2023-12-31: -$103.71M2024-12-31: -$2.54M2025-12-31: $340.99M$340.99M
2009-12-31Operating Income (USD)2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$340.99M—2026-02-26From 2025-01-01
2024-12-31-$2.54M—2026-02-26From 2024-01-01
2023-12-31-$103.71M—2026-02-26From 2023-01-01
2022-12-31-$148.44M—2025-02-25From 2022-01-01
2021-12-31-$177.72M—2024-02-27From 2021-01-01
2020-12-31-$174.76M—2023-02-27From 2020-01-01
2019-12-31-$99.45M—2022-02-28From 2019-01-01
2018-12-31-$94.22M—2021-03-01From 2018-01-01
2017-12-31-$57.41M—2020-03-13From 2017-01-01
2016-12-31-$48.61M—2019-03-14From 2016-01-01
2015-12-31-$39.44M—2018-03-12From 2015-01-01
2014-12-31-$45.77M—2017-02-27From 2014-01-01
2013-12-31-$30.72M—2016-02-26From 2013-01-01
2012-12-31-$33.89M—2015-03-02From 2012-01-01
2011-12-31-$49.59M—2014-03-10From 2011-01-01
2010-12-31-$34.36M—2013-03-11From 2010-01-01
2009-12-31-$13.74M—2012-03-06From 2009-01-01